Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study


Using a large European cohort, Nita Forouhi and colleagues investigate the association between the concentration of polyunsaturated fatty acids measured in plasma and risk of developing type 2 diabetes.


Vyšlo v časopise: Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study. PLoS Med 13(7): e32767. doi:10.1371/journal.pmed.1002094
Kategorie: Research Article
prolekare.web.journal.doi_sk: 10.1371/journal.pmed.1002094

Souhrn

Using a large European cohort, Nita Forouhi and colleagues investigate the association between the concentration of polyunsaturated fatty acids measured in plasma and risk of developing type 2 diabetes.


Zdroje

1. Eyre H, Kahn R, Robertson RM, Clark NG, Doyle C, Hong Y, et al. (2004) Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Circulation 109: 3244–3255. 15198946

2. Akinkuolie AO, Ngwa JS, Meigs JB, Djousse L (2011) Omega-3 polyunsaturated fatty acid and insulin sensitivity: a meta-analysis of randomized controlled trials. Clin Nutr 30: 702–707. doi: 10.1016/j.clnu.2011.08.013 21959352

3. Hartweg J, Perera R, Montori V, Dinneen S, Neil HA, Farmer A (2008) Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database Syst Rev: CD003205. doi: 10.1002/14651858.CD003205.pub2 18254017

4. Xun P, He K (2012) Fish Consumption and Incidence of Diabetes: meta-analysis of data from 438,000 individuals in 12 independent prospective cohorts with an average 11-year follow-up. Diabetes Care 35: 930–938. doi: 10.2337/dc11-1869 22442398

5. Wallin A, Di Giuseppe D, Orsini N, Patel PS, Forouhi NG, Wolk A (2012) Fish Consumption, Dietary Long-chain n-3 Fatty Acids, and Risk of Type 2 Diabetes: Systematic review and meta-analysis of prospective studies. Diabetes Care 35: 918–929. doi: 10.2337/dc11-1631 22442397

6. Wu JH, Micha R, Imamura F, Pan A, Biggs ML, Ajaz O, et al. (2012) Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis. Br J Nutr 107 Suppl 2: S214–S227. doi: 10.1017/S0007114512001602 22591895

7. Zheng JS, Huang T, Yang J, Fu YQ, Li D (2012) Marine N-3 polyunsaturated fatty acids are inversely associated with risk of type 2 diabetes in Asians: a systematic review and meta-analysis. PLoS ONE 7: e44525. doi: 10.1371/journal.pone.0044525 22984522

8. National Diet and Nutrition Survey. Results from Years 1, 2, 3 and 4 (combined) of the Rolling Programme (2008/2009–2011/2012). London. 2014. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/310995/NDNS_Y1_to_4_UK_report.pdf.

9. Kroger J, Zietemann V, Enzenbach C, Weikert C, Jansen EH, Doring F, et al. (2011) Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. AmJ ClinNutr 93: 127–142.

10. Alhazmi A, Stojanovski E, McEvoy M, Garg ML (2014) Macronutrient intake and type 2 diabetes risk in middle-aged Australian women. Results from the Australian Longitudinal Study on Women's Health. Public Health Nutr 17: 1587–1594. doi: 10.1017/S1368980013001870 23866795

11. Song Y, Manson JE, Buring JE, Liu S (2004) A prospective study of red meat consumption and type 2 diabetes in middle-aged and elderly women: the women's health study. Diabetes Care 27: 2108–2115. 15333470

12. van Dam RM, Willett WC, Rimm EB, Stampfer MJ, Hu FB (2002) Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care 25: 417–424. 11874924

13. Salmeron J, Hu FB, Manson JE, Stampfer MJ, Colditz GA, Rimm EB, et al. (2001) Dietary fat intake and risk of type 2 diabetes in women. AmJClinNutr 73: 1019–1026.

14. Ramsden CE, Zamora D, Leelarthaepin B, Majchrzak-Hong SF, Faurot KR, Suchindran CM, et al. (2013) Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ 346: e8707. doi: 10.1136/bmj.e8707 23386268

15. Choque B, Catheline D, Rioux V, Legrand P (2014) Linoleic acid: between doubts and certainties. Biochimie 96: 14–21. doi: 10.1016/j.biochi.2013.07.012 23900039

16. Ramsden CE, Zamora D, Majchrzak-Hong S, Faurot KR, Broste SK, Frantz RP, et al. (2016) Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968–73). BMJ 353: i1246. doi: 10.1136/bmj.i1246 27071971

17. Hodge AM, English DR, O'Dea K, Sinclair AJ, Makrides M, Gibson RA, et al. (2007) Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. AmJ ClinNutr 86: 189–197.

18. Patel PS, Sharp SJ, Jansen E, Luben RN, Khaw KT, Wareham NJ, et al. (2010) Fatty acids measured in plasma and erythrocyte-membrane phospholipids and derived by food-frequency questionnaire and the risk of new-onset type 2 diabetes: a pilot study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort. AmJ ClinNutr 92: 1214–1222.

19. Wang L, Folsom AR, Zheng ZJ, Pankow JS, Eckfeldt JH (2003) Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. AmJ ClinNutr 78: 91–98.

20. Krachler B, Norberg M, Eriksson JW, Hallmans G, Johansson I, Vessby B, et al. (2008) Fatty acid profile of the erythrocyte membrane preceding development of Type 2 diabetes mellitus. NutrMetab CardiovascDis 18: 503–510.

21. Langenberg C, Sharp S, Forouhi NG, Franks PW, Schulze MB, Kerrison N, et al. (2011) Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia 54: 2272–2282. doi: 10.1007/s00125-011-2182-9 21717116

22. Hodson L, Skeaff CM, Fielding BA (2008) Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 47: 348–380. doi: 10.1016/j.plipres.2008.03.003 18435934

23. Wang LY, Summerhill K, Rodriguez-Canas C, Mather I, Patel P, Eiden MY S., et al. (2013) Development and validation of a robust automated analysis of plasma phospholipid fatty acids for metabolic phenotyping of large epidemiological studies. Genome Med 5: 39. doi: 10.1186/gm443 23618465

24. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557–560. 12958120

25. Greenland S, Longnecker MP (1992) Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135: 1301–1309. 1626547

26. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J (2006) Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 189: 19–30. 16530201

27. Forouhi NG, Koulman A, Sharp SJ, Imamura F, Kroger J, Schulze MB, et al. (2014) Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study. Lancet Diabetes Endocrinol 2: 810–818. doi: 10.1016/S2213-8587(14)70146-9 25107467

28. Kaur G, Cameron-Smith D, Garg M, Sinclair AJ (2011) Docosapentaenoic acid (22:5n-3): a review of its biological effects. Prog Lipid Res 50: 28–34. doi: 10.1016/j.plipres.2010.07.004 20655949

29. Mahendran Y, Agren J, Uusitupa M, Cederberg H, Vangipurapu J, Stancakova A, et al. (2014) Association of erythrocyte membrane fatty acids with changes in glycemia and risk of type 2 diabetes. AmJClinNutr 99: 79–85. doi: 10.3945/ajcn.113.069740 24153340

30. Lankinen MA, Stancakova A, Uusitupa M, Agren J, Pihlajamaki J, Kuusisto J, et al. (2015) Plasma fatty acids as predictors of glycaemia and type 2 diabetes. Diabetologia 58: 2533–2544. doi: 10.1007/s00125-015-3730-5 26277381

31. Lemaitre RN, Tanaka T, Tang W, Manichaikul A, Foy M, Kabagambe EK, et al. (2011) Genetic loci associated with plasma phospholipid n-3 fatty acids: a meta-analysis of genome-wide association studies from the CHARGE Consortium. PLoS Genet 7: e1002193. doi: 10.1371/journal.pgen.1002193 21829377

32. Bloedon LT, Balikai S, Chittams J, Cunnane SC, Berlin JA, Rader DJ, et al. (2008) Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial. J Am Coll Nutr 27: 65–74. 18460483

33. Rhee Y, Brunt A (2011) Flaxseed supplementation improved insulin resistance in obese glucose intolerant people: a randomized crossover design. Nutr J 10: 44. doi: 10.1186/1475-2891-10-44 21554710

34. Hutchins AM, Brown BD, Cunnane SC, Domitrovich SG, Adams ER, Bobowiec CE (2013) Daily flaxseed consumption improves glycemic control in obese men and women with pre-diabetes: a randomized study. Nutr Res 33: 367–375. doi: 10.1016/j.nutres.2013.02.012 23684438

35. Gomes PM, Hollanda-Miranda WR, Beraldo RA, Castro AV, Geloneze B, Foss MC, et al. (2015) Supplementation of alpha-linolenic acid improves serum adiponectin levels and insulin sensitivity in patients with type 2 diabetes. Nutrition 31: 853–857. doi: 10.1016/j.nut.2014.12.028 25933493

36. Burdge G (2004) Alpha-linolenic acid metabolism in men and women: nutritional and biological implications. Curr Opin Clin Nutr Metab Care 7: 137–144. 15075703

37. Bhaswant M, Poudyal H, Brown L (2015) Mechanisms of enhanced insulin secretion and sensitivity with n-3 unsaturated fatty acids. J Nutr Biochem 26: 571–584. doi: 10.1016/j.jnutbio.2015.02.001 25841249

38. Whelan J (2008) The health implications of changing linoleic acid intakes. Prostaglandins Leukot Essent Fatty Acids 79: 165–167. doi: 10.1016/j.plefa.2008.09.013 18990554

39. Chowdhury R, Warnakula S, Kunutsor S, Crowe F, Ward HA, Johnson L, et al. (2014) Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med 160: 398–406. doi: 10.7326/M13-1788 24723079

40. Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS (2012) Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA 308: 1024–1033. doi: 10.1001/2012.jama.11374 22968891

41. Al-Khudairy L, Hartley L, Clar C, Flowers N, Hooper L, Rees K (2015) Omega 6 fatty acids for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev: CD011094. doi: 10.1002/14651858.CD011094.pub2 26571451

Štítky
Interné lekárstvo

Článok vyšiel v časopise

PLOS Medicine


2016 Číslo 7
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Eozinofilní granulomatóza s polyangiitidou
nový kurz

Betablokátory a Ca antagonisté z jiného úhlu
Autori: prof. MUDr. Michal Vrablík, Ph.D., MUDr. Petr Janský

Autori: doc. MUDr. Petr Čáp, Ph.D.

Farmakoterapie akutní a chronické bolesti

Získaná hemofilie - Povědomí o nemoci a její diagnostika

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Nemáte účet?  Registrujte sa

Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa